Back to ALK-B.COView full pipeline
Phase 3
Development Phase
0
Upcoming Catalysts
0
Historical Events
0
Regulatory Approvals
No Catalysts Found
No catalyst events have been recorded for this drug yet.
Competitive Landscape
0 competitors in Allergic Rhinoconjunctivitis
View Full LandscapeDrug Information
Patent & Exclusivity
No patent data available. Pre-approval drugs may not have Orange Book listings.
Drug Science
Mechanism of action & safety profile
Related Pipeline
Sublingual allergy immunotherapy tabletPhase 3
Allergic Rhinitis Due to Dermatophagoides Farinae
Grass (Phleum pratense) pollen allergen extractPhase 3
Rhinitis Allergic
ALK HDM tabletPhase 3
Asthma
ALK Grass tablet - use of compliance devicePhase 3
Allergy
AIT TabletPhase 3
House Dust Mite Allergy
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts